Stone, Jacqueline

Publications

Sort by

Co-Author Network

Phase 1b trial of an ibrutinib-based combination therapy in recurrent/refractory CNS lymphoma. Blood. 2018 Academic Article GET IT
Times cited: 222
Correction regarding data on blinatumomab-associated seizures. Nature reviews. Clinical oncology. 2016 Letter GET IT
Times cited: 1
Cancer-treatment-induced neurotoxicity--focus on newer treatments. Nature reviews. Clinical oncology. 2015 Review GET IT
Times cited: 240
The type III TGF-β receptor betaglycan transmembrane-cytoplasmic domain fragment is stable after ectodomain cleavage and is a substrate of the intramembrane protease γ-secretase. Biochimica et biophysica acta. 2010 Academic Article GET IT
Times cited: 22